|
1EZV
STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO-CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT
Deposited 2000-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Fragment:RESIDUES 4-58
|
Not recorded
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 4
SMA STIGMATELLIN A × 2
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
HEC HEME C × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
microseeding;pH 8;277 K;5 % PEG 4000, 100 mM Tris, 0.05 % Undecyl-maltoside, 1 micromolar stigmatellin, pH 8.0, microseeding, temperature 277K
|
Resolution 2.30 Å
R-free 0.254
|
|
1KB9
YEAST CYTOCHROME BC1 COMPLEX
Deposited 2001-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain I
4–58(55 aa)
Fragment:RESIDUES 4-58
|
Not recorded
|
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 1
UMQ UNDECYL-MALTOSIDE × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 3
SMA STIGMATELLIN A × 1
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 1
PIE 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol × 1
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 2
CDL CARDIOLIPIN × 1
FES FE2/S2 (INORGANIC) CLUSTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;PEG4000, pH 8, VAPOR DIFFUSION, SITTING DROP
|
Resolution 2.30 Å
R-free 0.249
|
|
1KYO
YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
Deposited 2002-02-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain I
1–57(57 aa)
Fragment:RESIDUES 1-57
Chain T
1–57(57 aa)
Fragment:RESIDUES 1-57
|
Not recorded
|
HEC HEME C × 7
SMA STIGMATELLIN A × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PEG4000, 20 mM Tris, 0.05 % Undecyl-maltopyranoside, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.97 Å
R-free 0.268
|
|
1P84
HDBT inhibited Yeast Cytochrome bc1 Complex
Deposited 2003-05-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 18
PDB declaration: octadecameric
|
Chain I
3–57(55 aa)
|
Not recorded
|
3PH 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE × 4
UMQ UNDECYL-MALTOSIDE × 2
HEC HEME C × 6
DBT 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE × 2
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
3PE 1,2-Distearoyl-sn-glycerophosphoethanolamine × 4
PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2
CDL CARDIOLIPIN × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;PEG4000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.50 Å
R-free 0.252
|
|
2IBZ
Yeast Cytochrome BC1 Complex with Stigmatellin
Deposited 2006-09-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain I
0–65(66 aa)
|
Not recorded
|
HEC HEME C × 3
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 1
SMA STIGMATELLIN A × 1
FES FE2/S2 (INORGANIC) CLUSTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;precipitant PEG4000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.256
|
|
3CX5
Structure of complex III with bound cytochrome c in reduced state and definition of a minimal core interface for electron transfer.
Deposited 2008-04-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain I
2–66(65 aa)
Fragment:RESIDUES 2-66
Chain T
2–66(65 aa)
Fragment:RESIDUES 2-66
|
Not recorded
|
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
UMQ UNDECYL-MALTOSIDE × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 7
SMA STIGMATELLIN A × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
7PH (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Microbatch (paraffin oil);pH 7.5;277 K;1M Sucrose, 10% DMSO, 20mM Tris pH 7.5, 80mM NaCl, 0.05 % UM, 1 M stigmatellin, 5% PEG 4000, Microbatch (paraffin oil), temperature 277K
|
Resolution 1.90 Å
R-free 0.263
|
|
3CXH
Structure of yeast complex III with isoform-2 cytochrome c bound and definition of a minimal core interface for electron transfer.
Deposited 2008-04-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain I
2–66(65 aa)
Fragment:RESIDUES 2-66
Chain T
2–66(65 aa)
Fragment:RESIDUES 2-66
|
Not recorded
|
UMQ UNDECYL-MALTOSIDE × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 7
SMA STIGMATELLIN A × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
CN6 (2R,5R,11S,14R)-2-(butanoyloxy)-5,8,11-trihydroxy-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
7PH (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
Microbatch (Paraffin oil);pH 7.5;277 K;1M Sucrose, 10% DMSO, 20mM Tris pH 7.5, 80mM NaCl, 0.05 % UM, 1 M stigmatellin, 5% PEG 4000, Microbatch (Paraffin oil), temperature 277K
|
Resolution 2.50 Å
R-free 0.256
|
|
4PD4
Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
Deposited 2014-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 22
PDB declaration: 22-meric
|
Chain I
2–58(57 aa)
Fragment:UNP residues 2-58
|
Not recorded
|
UMQ UNDECYL-MALTOSIDE × 2
3PH 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE × 6
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
AOQ 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione × 2
3PE 1,2-Distearoyl-sn-glycerophosphoethanolamine × 2
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277.2 K;polyethylene glycol 4000, DMSO, Sucrose, Potassium phosphate, n-undecyl-?-D-maltopyranoside, atovaquone
|
Resolution 3.04 Å
R-free 0.297
|
|
6T0B
The III2-IV(5B)2 respiratory supercomplex from S. cerevisiae
Deposited 2019-10-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 46
PDB declaration: 46-meric
|
Chain I
1–66(66 aa)
Chain T
1–66(66 aa)
|
Not recorded
|
CDL CARDIOLIPIN × 8
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 26
HEM PROTOPORPHYRIN IX CONTAINING FE × 4
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 7
HEC HEME C × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
CU COPPER (II) ION × 2
HEA HEME-A × 4
CA CALCIUM ION × 2
MG MAGNESIUM ION × 2
CUA DINUCLEAR COPPER ION × 2
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;3 microliter of sample applied to negatively glow discharged grid, blot force -10; blotting time 8.5 s
|
Resolution 2.80 Å
|
|
6T15
The III2-IV(5B)1 respiratory supercomplex from S. cerevisiae
Deposited 2019-10-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 33
PDB declaration: 33-meric
|
Chain I
1–66(66 aa)
Chain T
1–66(66 aa)
|
Not recorded
|
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 18
HEM PROTOPORPHYRIN IX CONTAINING FE × 4
CDL CARDIOLIPIN × 7
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 6
HEC HEME C × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
CU COPPER (II) ION × 1
HEA HEME-A × 2
MG MAGNESIUM ION × 1
CUA DINUCLEAR COPPER ION × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;3 microliter of sample applied to negatively glow discharged grid, blot force -10; blotting time 8.5 s
|
Resolution 3.29 Å
|
|
6YMX
CIII2/CIV respiratory supercomplex from Saccharomyces cerevisiae
Deposited 2020-04-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 32
PDB declaration: 32-meric
|
Chain I
5–58(54 aa)
Chain T
4–57(54 aa)
|
Not recorded
|
CU COPPER (II) ION × 1
HEA HEME-A × 2
PTY PHOSPHATIDYLETHANOLAMINE × 7
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
CUA DINUCLEAR COPPER ION × 1
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 5
ZN ZINC ION × 1
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
7PH (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.17 Å
|
|
8E7S
III2IV2 respiratory supercomplex from Saccharomyces cerevisiae with 4 bound UQ6
Deposited 2022-08-24
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 44
PDB declaration: 44-meric
|
Chain E
1–66(66 aa)
Chain e
1–66(66 aa)
|
Not recorded
|
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 24
FES FE2/S2 (INORGANIC) CLUSTER × 2
CDL CARDIOLIPIN × 10
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 6
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 4
HEA HEME-A × 4
CU COPPER (II) ION × 2
CUA DINUCLEAR COPPER ION × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
8EC0
III2IV respiratory supercomplex from Saccharomyces cerevisiae cardiolipin-lacking mutant
Deposited 2022-08-31
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain E
1–66(66 aa)
Chain e
1–66(66 aa)
|
Not recorded
|
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 15
PGT (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE × 7
FES FE2/S2 (INORGANIC) CLUSTER × 2
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 4
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
CU COPPER (II) ION × 1
HEA HEME-A × 2
CUA DINUCLEAR COPPER ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
8YHQ
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex in pyraclostrobin-bound state
Deposited 2024-02-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain R
4–58(55 aa)
|
Not recorded
|
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
A1D6K methyl ~{N}-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-~{N}-methoxy-carbamate × 2
7PH (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS,0.1%DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.42 Å
|
|
8YIL
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex in YF24228-bound state
Deposited 2024-02-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain T
4–58(55 aa)
|
Not recorded
|
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
86T metyltetraprole × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS,0.1%DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.58 Å
|
|
8YIN
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex in YF23694-bound state
Deposited 2024-02-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain T
4–58(55 aa)
|
Not recorded
|
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
A1D6O 1-[2-[(4,6-dimethyl-1,3-benzothiazol-2-yl)sulfanylmethyl]-3-methyl-phenyl]-4-methyl-1,2,3,4-tetrazol-5-one × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS, 0.1% DDM
cryo-EM vitrification conditions
Cryogen NITROGEN
|
Resolution 2.74 Å
|
|
8YIO
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex in azoxystrobin-bound state
Deposited 2024-02-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain T
4–58(55 aa)
|
Not recorded
|
AZO METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE × 2
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS,0.1%DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.35 Å
|
|
8ZJC
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex
Deposited 2024-05-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain T
4–58(55 aa)
|
Not recorded
|
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS,0.1%DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
8ZMT
Cryo-EM structure of Saccharomyces cerevisiae bc1 complex in Metyltetraprole-bound state
Deposited 2024-05-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 20
PDB declaration: eicosameric
|
Chain I
4–58(55 aa)
Chain T
4–58(55 aa)
|
Not recorded
|
A1D6P 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-1,2,3,4-tetrazol-5-one × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
HEM PROTOPORPHYRIN IX CONTAINING FE × 6
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 3
FES FE2/S2 (INORGANIC) CLUSTER × 2
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS, 0.1% DDM
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.52 Å
|
|
9BPB
Tethered respiratory III2IV2 supercomplex from Saccharomyces cerevisiae
Deposited 2024-05-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 42
PDB declaration: 42-meric
|
Chain I
1–66(66 aa)
Chain S
1–66(66 aa)
|
Not recorded
|
CDL CARDIOLIPIN × 8
6PH (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate × 2
8PE (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate × 2
CN5 (5S,11R)-5,8,11-trihydroxy-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5,11-diphosphaoctadec-1-yl pentadecanoate × 1
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 4
HEM PROTOPORPHYRIN IX CONTAINING FE × 4
9PE (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate × 2
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 6
HEC HEME C × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 8
PTY PHOSPHATIDYLETHANOLAMINE × 10
HEA HEME-A × 4
CU COPPER (II) ION × 2
CA CALCIUM ION × 2
CN3 (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate × 2
MG MAGNESIUM ION × 2
CUA DINUCLEAR COPPER ION × 2
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;3 uL of sample, 5 s blot time, 30 s hold time, 0 blot force.
|
Resolution 2.57 Å
|
|
9ETZ
III2IV respiratory supercomplex from Saccharomyces cerevisiae
Deposited 2024-03-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 32
PDB declaration: 32-meric
|
Chain I
2–58(57 aa)
Chain T
2–58(57 aa)
|
Not recorded
|
CDL CARDIOLIPIN × 11
HEM PROTOPORPHYRIN IX CONTAINING FE × 4
PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE × 26
PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE × 6
UQ6 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL × 2
HEC HEME C × 2
FES FE2/S2 (INORGANIC) CLUSTER × 2
CU COPPER (II) ION × 1
HEA HEME-A × 2
CA CALCIUM ION × 1
MG MAGNESIUM ION × 1
CUA DINUCLEAR COPPER ION × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.40 Å
|